摘要
目的观察低分子肝素钙联合参麦注射液治疗慢性肺源性心脏病的效果。方法选取50例慢性肺源性心脏病患者，并随机分为观察组和对照组，每组25例，每组均给予持续低流量吸氧、控制感染、祛痰平喘、强心利尿等常规治疗，观察组在常规治疗基础上加用低分子肝素钙联合参脉注射液治疗。结果观察组显效19例，有效6例，无效0例，总有效率100％；对照组显效11例，有效9例，无效5例，总有效率80％，两组总有效率比较差异有极显著性（P〈0．01）。结论应用低分子肝素钙联合参脉注射液治疗，能有效地改善临床症状，提高动脉血氧分压，降低动脉血二氧化碳分压，是治疗慢胜肺源性心脏病的有效方法。
Objective To explore the efficacy of low molecular weight heparins calcium combined with Shengmaiinjection in the treatment of chronic cor puhnonale. Methods 50 patients with chronic cot pulmonale were randomly assigned to receive conventional therapy including administration of continuous low-flow oxygen, antibiotics, expectorants, bronchodilators, digitalis glycosides, and diuretics （control group, 25 patients）, or the same conventional therapy plus low molecular weight heparins calcium and Skangmaiinjection （study group, 25 patients）. Results There was signigicant difference in the total effective rate between the study group and the control group in the （100% vs. 80%, P〈0.05）. Conclusions Low molecular weight heparins calcium combined with Shengmai injection is effective in improving clinical symptoms, and increasing PaO2 while reducing PaCO2, thus is an effective therapy for chronic pulmonary heart disease.
出处
《国际医药卫生导报》
2010年第12期1467-1469,共3页
International Medicine and Health Guidance News
关键词
低分子肝素钙
参脉注射液
慢性肺源性心脏病
Low molecular weight heparins calcium
Shenmai injection
Chronic puhnonary heart disease
